Skip to main content

Table 4 Seroprevalence of HIV-1, HBV, HCV and HDV among Pregnant Women

From: Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy

  

Hospital

Total number of positives

Overall seroprevalence

Antenatal clinic 1

Antenatal clinic 2

Antenatal clinic 3

Total number tested

506

249

250

151a

(%)

Rate of biomarker (%)

anti-HIV-1 antibodies

11.1

8.4

3.2

85

8.5

HbsAg

6.3

8.4

4.4

64

6.4

anti-HBs

24.3

23.2

22.4

237

23.6

HBeAg

12.1

11.9

1

82

8.2

anti-Hbe

18.8

16.8

17.6

182

18.1

anti-HBc

37.0

28.4

34.8

347

34.5

anti-HCV

0.4

0.2

0.2

8

0.8

anti-HDV

   

40

4.0

  1. aTotal number of women infected with HIV, HBV or HCV